Precision Payload: ADCs for Solid Tumors and the Essential Role of Oncology Pharmacists in TRAE Identification and Management

With increasing use of antibody–drug conjugates (ADCs) for the treatment of various tumor types, it is important to know how to manage treatment-related adverse events (TRAEs). Learners will be able to identify and manage TRAEs, tailor individual treatment plans, and discuss the mechanisms by which ADCs contribute to different safety profiles.

Share

Program Content

Events

  • Live Event Precision Payload
    Precision Payload: ADCs for Solid Tumors and the Essential Role of Oncology Pharmacists in TRAE Identification and Management
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

Current and Emerging ADCs
Introduction to ADCs in Solid Tumors: Basics, Relevance, and Current & Emerging Targeted Therapies
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 12, 2025

Expires: November 11, 2025

ADC AE Management
ADC AE Identification, Management, and Communication/Care Coordination
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 12, 2025

Expires: November 11, 2025

Provided by

ProCE Banner

Provided by ProCE, LLC in collaboration with Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner